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MaOBJECTIVES This study sought to evaluate inter–core lab variability in quantitative coronary angiography (QCA)
analysis of bifurcation lesions.
BACKGROUND QCA of bifurcation lesions is challenging. To date there are no data available on the inter–core lab
variability of bifurcation QCA analysis.
METHODS The randomized Tryton IDE (Tryton Pivotal IDE Coronary Bifurcation Trial) compared the Tryton Side Branch
Stent (Tryton Medical, Durham, North Carolina) with balloon angioplasty as side branch treatment. QCA was performed
in an angiographic subcohort (n ¼ 326) at 9-month follow-up. Inter-core lab variability of QCA analysis between the
Cardiovascular Research Foundation and the Cardialysis core labs was evaluated before and after alignment of the used
QCA methodology using angiographic data derived from this angiographic follow-up cohort.
RESULTS In the original analysis, before alignment of QCA methodology, the mean difference between the core labs
(bias) was large for all QCA parameters with wide 95% limits of agreement (1.96  SD of the bias), indicating marked
variability. The bias of the key angiographic endpoint of the Tryton trial, in-segment percentage diameter stenosis (%DS)
of the side branch, was 5.5% (95% limits of agreement: –26.7% to 37.8%). After reanalysis, the bias of the in-segment
%DS of the side branch reduced to 1.8% (95% limits of agreement: –16.7% to 20.4%). Importantly, after alignment of
the 2 core labs, there was no longer a difference between both treatment groups (%DS of the side branch: treatment
group A vs. group B: 34.4  19.4% vs. 32.4  16.1%, p ¼ 0.340).
CONCLUSIONS Originally, a marked inter–core lab variability of bifurcation QCA analysis was found. After alignment of
methodology, inter–core lab variability decreased considerably and impacted angiographic trial results. This latter ﬁnding
emphasizes the importance of using the same methodology among different core labs worldwide. (Tryton Pivotal
Prospective, Single Blind, Randomized Controlled Study to Evaluate the Safety & Effectiveness of the Tryton Side Branch
Stent Used With DES in Treatment of de Novo Bifurcation Lesions in the Main Branch & Side Branch in Native Coronaries
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ABBR EV I A T I ON S
AND ACRONYMS
%DS = percentage diameter
stenosis
CI = conﬁdence interval
CRF = Cardiovascular Research
Foundation
IDE = investigational device
exemption
MLD = minimal lumen diameter
QCA = quantitative coronary
angiography
RVD = reference vessel
diameter
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306E ver since the late 1970s, visual esti-mation of the severity of a stenosison coronary angiography has been
regarded as unreliable due to a marked intra-
and interobserver variability (1,2). Therefore,
quantitative coronary angiography (QCA) was
introduced in the mid-1980s to provide an
objective and reproducible quantiﬁcation of
coronary lesions (3,4). QCA parameters have
been widely used as primary and secondary
endpoints in numerous randomized clinical
trials evaluating the efﬁcacy of new technol-
ogies in percutaneous coronary interventions
and the effect of new pharmaceutical agentson coronary artery disease progression/regression
(5–7).
Due to the fractal geometry of the coronary tree,
there is a natural tapering of the bifurcation, with
differences in reference vessel diameter (RVD)
among the proximal main branch, distal main branch,
and side branch (8,9). Due to this natural tapering,
the interobserver variability of visual estimation of
lesion severity increases even more in bifurcation
lesions (10). Furthermore, conventional QCA algo-
rithms have the limitation of being inaccurate in
bifurcation lesions because they have been devel-
oped and validated in a single straight coronary
segment (11). To improve the accuracy of QCA in
bifurcation lesions, dedicated bifurcation algorithms
were developed, which subsequently have been
used in recent clinical trials on bifurcation treatment
(12–16).
To eliminate the potential bias stemming from the
investigators, QCA analysis in clinical trials is usually
performed at independent core laboratories (core
labs). These core labs aim to provide unbiased and
reproducible results by using validated QCA software
and by using standard operating procedures during
QCA analysis. Although intraobserver and interob-
server variability of bifurcation QCA algorithms have
been investigated before (14,16,17), to date no data
are available on the differences in bifurcation QCA
measurements between core labs. This study aimed
to examine inter–core lab variability by comparing the
QCA results of 2 core labs using data from the
9-month angiographic follow-up cohort of the ran-
domized trial on the Tryton Side Branch Stent (Tryton
Medical, Durham, North Carolina).
METHODS
SETTING. Tryton IDE (Tryton Pivotal IDE Coronary
Bifurcation Trial), an investigational device exemp-
tion (IDE) randomized trial, compared the Tryton SideBranch Stent with side branch balloon angioplasty,
both in combination with a regular drug-eluting stent
in the main branch, for the treatment of de novo true
coronary bifurcation lesions. The primary endpoint
(powered for noninferiority), at 9-month follow-up,
was the difference in the occurrence of target vessel
failure, deﬁned as the composite of cardiac death,
Q-wave or non–Q-wave target vessel myocardial
infarction (>3 the upper limit of normal of creatine
kinase isoenzyme), and target vessel revasculariza-
tion. The key secondary endpoint (powered for
superiority) was in-segment percentage diameter
stenosis (%DS) of the side branch in a pre-speciﬁed
subgroup of 374 subjects (with an expected loss to
follow-up of 15%) undergoing planned repeat angi-
ography at 9 months (the angiographic follow-up
cohort).
Two core labs were assigned to perform different
types of analyses in the angiographic follow-up
cohort of the Tryton IDE trial. The Cardiovascular
Research Foundation (CRF, New York, New York)
was assigned to perform 2-dimensional QCA analysis
of the complete angiographic follow-up cohort.
Cardialysis B.V. (Rotterdam, the Netherlands) was
assigned to perform 3-dimensional QCA and intra-
vascular ultrasound analyses and for this purpose
9-month follow-up angiograms of 130 subjects
included in the angiographic follow-up cohort were
available at Cardialysis. Besides 3-dimensional QCA
and intravascular ultrasound analyses, Cardialysis
also performed 2-dimensional QCA analysis in this
subgroup. The inter–core lab variability of the
9-month 2-dimensional QCA analysis between the 2
core labs was investigated in these 130 subjects.
This initial analysis indicated diverging angiographic
results between the 2 core labs (Figure 1A). Thereafter,
both core labs disclosed and shared their QCA anal-
ysis plans to unravel potential explanations for these
differences. Both core labs decided to perform a
reanalysis of the total angiographic follow-up cohort
using an identical QCA analysis plan, which they had
agreed on (Table 1).
INITIAL QCA ANALYSIS PLAN OF CRF. At the start of
the Tryton IDE trial, the dedicated bifurcation QCA
algorithms were not yet validated against precision
phantoms. Therefore, the initial QCA analysis plan of
the trial, approved by the U.S. Food and Drug Admin-
istration and used for the main publication, included
the use of a conventional single-vessel QCA algorithm
(QAngio XA, version 7.2.34, Medis Medical Imaging
Systems, Leiden, the Netherlands). For each bifurca-
tion, 2 analyses were performed: one from the prox-
imal main branch to the distal main branch, and the
FIGURE 1 Inﬂuence of Core Lab Alignment on the QCA Trial Results
(A) The divergent results are shown of the initial quantitative coronary analysis (QCA), in a
subgroup of 130 patients, with regard to in-segment diameter stenosis of the side branch
at 9-month follow-up. (B) After reanalysis of the complete angiographic cohort (n ¼ 311),
both core labs show similar results.
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307other from the proximal main branch to the side
branch. First, calibration was performed using the
guiding catheter and then, the region of interest was
deﬁned by indicating its proximal (i.e., in the prox-
imal main branch) and distal (i.e., in the side branch or
distal main branch) boundaries (Figure 2B). Hereafter,
the QCA software automatically detected the vessel
contour based on the change in brightness of the
pixels (Figure 2C) (4). Then, the analysts were allowed
to manually edit the vessel contour whenever the
contour did not appeared to be smooth or appropri-
ately delineated (Online Figure 1). Because conven-
tional single-vessel QCA software does not recognize
the side branch origin, segmentation of the bifurca-
tion lesion was performed manually, with the carinal
point as the beginning of the side branch segment
(Figure 2E). For the side branch, a single point 5 mm
distal to the balloon/stent edge was taken as the
reference vessel diameter (RVD) (Figure 2F). The
%DS was calculated as follows: (RVD of the side
branch – minimal lumen diameter [MLD] of the
side branch) / RVD of the distal side branch (Figure 2F).
For the main branch, the RVD was deﬁned as
the average of the reference diameter in the
“normal” segments proximal and distal to the stent.
The %DS in the main branch was calculated by using
the MLD and the averaged RVD. QCA measurements
were performed on a single “worst” projection (i.e.,
the projection in which the stenosis looks most
severe).
INITIAL QCA ANALYSIS PLAN OF CARDIALYSIS.
Cardialysis used a dedicated bifurcation software al-
gorithm for their QCA analysis on bifurcation lesions
(Coronary Angiography Analysis System [CAAS],
version 5.9, Pie Medical Imaging, Maastricht, the
Netherlands) (13,18). For each bifurcation, only 1
analysis needed to be performed. The bifurcated re-
gion of interest—including the proximal main branch,
distal main branch, and side branch—was deﬁned by
indicating its proximal (i.e., in the proximal main
branch) and distal (i.e., in both the side branch and
the distal main branch) boundaries (Figure 3A). After
the automatic vessel contour detection (Figure 3B),
analysts were not allowed to manually edit the vessel
contour, except in the cases where the vessel contour
was erroneously detecting a side branch or other
overlapping contours instead of the vessel contour
itself (Online Figure 2). The point of bifurcation is
automatically determined by the software and is
deﬁned as the mid-point of the largest circle that
can be ﬁtted in the bifurcation area, touching all
3 contours (Figure 3C) (19). The centerlines of each of
the 3 segments meet at the point of bifurcation(Figure 3C). Segmentation of the bifurcation in 3
individual segments was performed automatically
using the point of bifurcation and centerlines as
previously described (19). The %DS was automatically
calculated using the interpolated RVD at the MLD
site of each segment (Figures 3E to 3G). All QCA
measurements were performed on at least 2 pro-
jections (if available), and the average from all
projections were reported.
ALIGNMENT OF QCA ANALYSIS PLANS BETWEEN BOTH
CORE LABS FOR THE REANALYSIS. After establishing
the differences in QCA plans, the 2 core labs agreed to
perform a post-hoc reanalysis. It was decided to use
TABLE 1 Initial QCA Analysis Plans of Both Core Laboratories and After Alignment
Initial QCA Analysis Plan CRF Initial QCA Analysis Plan Cardialysis Aligned QCA Analysis Plan for Reanalysis
QCA software used
Software type QAngio XA (Medis) CAAS (Pie Medical) CAAS
Version Version 7.2.34 Version 5.9 Version 5.9 (Cardialysis) and 5.11 (CRF)
Algorithm used Single-vessel algorithm, separately
applied on the main and side branch
Dedicated bifurcation algorithm Dedicated bifurcation algorithm
QCA analysis
Vessel contour
detection
Manual editing was allowed after
automatic vessel contour detection
Automatic contour detection with
restricted use of manual editing
Automatic contour detection with
restricted use of manual editing
Segmentation User-deﬁned, manual segmentation Automatic segmentation Automatic segmentation
RVD of the MB The average of the distal and proximal
user-deﬁned MB references
Interpolated reference automatically
generated by the software
Interpolated reference automatically
generated by the software
RVD of the SB User-deﬁned distal SB segment Interpolated reference automatically
generated by the software
Interpolated reference automatically
generated by the software
Number of views
used
Single, “worst” view was used Average of $2 views to account
for lumen eccentricity
Single, “worst” view was used
CAAS ¼ Coronary Angiography Analysis System; CRF ¼ Cardiovascular Research Foundation; MB ¼ main branch; QCA ¼ quantitative coronary angiography; RVD ¼ reference
vessel diameter; SB ¼ side branch.
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308the dedicated CAAS bifurcation software for rean-
alysis, considering the superior accuracy and preci-
sion of this method compared with single-vessel
algorithms (12). After delineating the region of inter-
est and the automatic detection of the vessel con-
tours, the analysts were not allowed to manually edit
the vessel contour, except in cases were the vessel
contour was erroneously not following the vessel
contour, as previously described (Online Figure 2).
Segmentation of the bifurcation was performed
automatically by the software and the %DS was
calculated using the interpolated RVD at the site of
the MLD in each segment. All QCA measurements
were performed on a single worst projection. Both
core labs performed their QCA on exactly the same
frame, which was selected by the CRF core lab.
STATISTICAL ANALYSES. The individual signed dif-
ferences of both core labs were averaged; the mean
of these signed differences (bias) was used as a
measure of accuracy and the standard deviation as
a measure of precision (20). The agreement between
both core labs with regard to the measurement of
%DS of the side branch (in-segment) was evaluated
by nonparametric orthogonal regression analysis us-
ing the Passing-Bablok method (21). The differences
in %DS of the side branch between core labs were also
displayed using Bland-Altman plots: the mean of both
core lab measurements were plotted on the horizontal
axis against the individual signed differences of both
core labs on the vertical axis. The 95% limits of
agreement (mean difference [bias]  1.96 SD of the
bias) were determined as the measure of variability.
For the Passing-Bablok regression analysis, STATA(version 12, StataCorp LP, College Station, Texas) was
used. All other statistical analyses were performed
using the SPSS software package (version 21.0, IBM,
Chicago, Illinois).
RESULTS
INTER–CORE LAB VARIABILITY. Inter–core lab vari-
ability of the initial QCA analysis of the 130 subjects
is shown in Table 2. Core lab A systematically
measured larger RVD, MLD, and %DS in both main
branch and side branch compared with Core Lab B.
Furthermore, the 95% limits of agreement were wide
for all QCA parameters, indicating a marked vari-
ability between both core labs. The average difference
in the in-segment %DS of the side branch (the key
secondary endpoint of the Tryton IDE trial, powered
for superiority) was 5.54%, with the 95% limits of
agreement between –26.74% and 37.82% (Figure 4).
Passing-Bablok orthogonal linear regression analysis
showed systematic as well as proportional bias be-
tween both core labs with regard to the measurement
of in-segment %DS of the side branch, with an inter-
cept of 7.1% (95% conﬁdence interval [CI]: 4.5% to
10.0%) and a slope of 0.62 (95% CI: 0.50 to 0.74)
(Figure 4).
From the 374 patients included in the pre-speciﬁed
angiographic cohort, 326 patients returned for repeat
angiography (87%). From these 326 patients, 311
matched cases were used to assess the inter–core
lab variability after QCA reanalysis. In 15 cases,
angiography was not available for both core labs due
to missing or corrupt CDs. After reanalysis of the total
angiographic cohort using the same QCA analysis
FIGURE 2 Initial QCA Analysis Plan of CRF Using a Single-Vessel Algorithm
(A) Diagnostic angiogram of a patient with a left anterior descending–diagonal branch bifurcation lesion. QCA was performed using the
conventional single-vessel algorithm of QAngio XA (Medis) software. The region of interest of the diagonal branch was deﬁned by indicating
the proximal and distal boundaries (B; long white arrows). Hereafter, the QCA software automatically detected the vessel contour based on the
change in brightness of the pixels (C). (D) The software detected the contour in the so-called polygon of conﬂuence. Note that the software
detected the outermost vessel wall, opposite to the side branch ostium, as vessel contour (short white arrows). Then, segmentation is
performed manually. (E) Two examples of different segmentations with different side branch origins (green line 1 vs. orange line 2) are shown,
illustrating the potential bias introduced by the manual segmentation. (F) The diameter function as displayed in the QCA report. Note that a
difference in segmentation of the side branch origin (green line 1 vs. orange line 2), results in a difference of in-segment side branch minimal
lumen diameters (0.72 mm [yellow arrow] vs. 1.11 mm [white arrow]), because the true minimal lumen diameter of the complete region of
interest (0.72 mm) was not included in the side branch segment by the second segmentation (orange line 2). (G) The percentage diameter
stenosis was calculated for the initial trial results by using the diameter of the distal normal segment as the reference vessel diameter. Note
how differences in side branch segmentation resulted in differences in percentage diameter stenosis of the side branch. Note that this ﬁgure is
included for illustrative purposes and it does not represent actual analyses performed in the trial. CRF ¼ Cardiovascular Research Foundation;
QCA ¼ quantitative coronary angiography.
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FIGURE 3 Initial QCA Analysis Plan of Cardialysis Using a Bifurcation Algorithm
QCA analysis of the same bifurcation lesion as in Figure 2, now performed using the dedicated bifurcation algorithm of the Coronary
Angiography Analysis System (CAAS) software. The bifurcated region of interest was deﬁned by indicating the boundaries in the proximal main
branch, distal main branch, and side branch (A; white arrows). After automatic detection of the vessel contour (B), analysts were not allowed to
further edit the vessel contour manually. (C) The point of bifurcation (POB) and the 3 centerlines. Before the software calculates the QCA
parameters, the analysts deﬁned the proximal and distal ends of the main branch stent and the distal end of the Tryton stent/balloon in the side
branch (D; white lines). (E) The 3 segments of the bifurcation (segments 2, 3, and 5) plus the proximal and distal 5-mm stent/balloon edges
(segments 1, 4, and 6) are shown. (F) The QCA diameter function of the proximal main branch and distal daughter vessels (i.e., distal main
branch and side branch) is shown. Note that each subsegment has its own interpolated reference diameter function, based on the complete
bifurcated region of interest (white vertical lines corresponding with the white lines in D, indicating the stent/balloon edges). (G) The QCA
parameters are shown as they are displayed in the QCA report. Note that the in-segment side branch stenosis calculation is based on the
interpolated reference diameter at the site of the minimal lumen diameter. Note that this ﬁgure is included for illustrative purposes and does
not represent actual analyses performed in the trial. QCA ¼ quantitative coronary angiography.
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310plan with the same frame and QCA bifurcation soft-
ware, less systematic bias was observed (Table 2). The
side branch in-segment QCA measurements were
almost identical between both core labs; only smallaverage differences were observed with regard to
the MLD (–0.0297 mm; 95% limits of agreement:
–0.4683 to 0.4089 mm) and the RVD (0.0227 mm;
95% limits of agreement: –0.4193 to 0.4647 mm),
TABLE 2 Table Showing the Inter–Core Lab Variability Before and After Alignment of Core Lab Methodologies
Initial Analysis (n ¼ 130) After Reanalysis of Both Core Labs (n ¼ 311)
Mean Signed
Differences (Bias)
Standard Deviation
(Precision)
95% Limits
of Agreement
Mean Signed
Differences (Bias)
Standard Deviation
(Precision)
95% Limits of
Agreement
Main branch
RVD, mm 0.2710 0.4216 –0.5553 to 1.0973 –0.0108 0.3464 –0.6681 to 0.6897
In-segment MLD, mm 0.1445 0.4420 –0.7218 to 1.0108 –0.0101 0.2652 –0.5299 to 0.5097
In-segment %DS, % 2.81 13.42 –23.47 to 29.11 –0.04 11.44 –22.46 to 22.38
In-stent MLD, mm 0.2030 0.4271 –0.6341 to 1.0401 –0.0084 0.3006 –0.5976 to 0.5808
In-stent %DS, % 0.48 12.10 –23.24 to 24.20 0.69 11.85 –22.54 to 23.92
Side branch
RVD, mm 0.2240 0.3376 –0.4377 to 0.8857 0.0227 0.2255 –0.4193 to 0.4647
In-segment MLD, mm 0.0322 0.4574 –0.8643 to 0.9287 –0.0297 0.2238 –0.4683 to 0.4089
In-segment %DS, % 5.54 16.47 –26.74 to 37.82 1.84 9.45 –16.68 to 20.36
%DS ¼ percentage diameter stenosis; MLD ¼ minimal lumen diameter; RVD ¼ reference vessel diameter.
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311resulting in an average difference in %DS of 1.8%
(95% limits of agreement: –16.7% to 20.4%) (Figure 4).
Finally, orthogonal linear regression analysis showed
a marked improvement in reproducibility between
core labs with regard to the measurement of in-
segment %DS of the side branch. The intercept of
the orthogonal regression line was close to 0%, with
0% being enclosed in the 95% CI (intercept: 0.8%,
95% CI: –0.8% to 2.5%), suggesting there was no
systematic bias. The slope of the orthogonal regres-
sion line was closer to the identity line with the
identity line almost being enclosed in the 95% CI,
suggesting only a minimal proportional bias between
both core labs after reanalysis (slope: 0.94, 95%
CI: 0.88 to 0.99) (Figure 4).
Initial QCA analysis in the subgroup of 130 patients
showed diverging results between both core labs
with regard to the Tryton IDE trial key secondary
endpoint of in-segment %DS of the side branch
(Figure 1A). However, after complete reanalysis using
contemporary bifurcation QCA software without the
routine use of manual contour editing and manual
segmentation, both core labs showed similar results
with regard to in-segment %DS of the side branch
(Figure 1B).
DISCUSSION
Our study, for the ﬁrst time, has highlighted a
marked inter–core lab variability in bifurcation QCA
measurements due to the use of different QCA soft-
ware and methodology. After using the same QCA
bifurcation software and aligning the methodology
of the QCA core labs, the inter–core lab variability
improved considerably. Furthermore, after aligning
the QCA methodology, we have demonstrated
that the trial results were affected. These ﬁndingsemphasize the importance of standardization of
QCA methodology among the different core labs.
The steering committee did acknowledge the
methodological differences between core labs that
have been raised retrospectively after the database
have been locked for the IDE submission to the
U.S. Food and Drug Administration. During the
designing phase of the trial, however, the validation
of the CAAS bifurcation QCA algorithm against a
precision bifurcation phantom model was not yet
published (14), and therefore the bifurcation algo-
rithm not yet integrated in the core lab responsible
for the baseline and follow-up QCA analyses. It was
decided to report the data according to the initial
approved methodological plan and analysis in the
main paper, while reporting the post-hoc QCA
results using the bifurcation software in the Online
Appendix (22).
USE OF SINGLE-VESSEL VERSUS DEDICATED
BIFURCATION SOFTWARE. One of the potential
explanations for the differences in the initial anal-
ysis was the use of a single-vessel QCA algorithm,
which is less accurate than a dedicated bifurcation
algorithm is and introduces a systematic bias for
several reasons (8,12). Due to the fractal geometry of
the epicardial coronary tree, there is a natural
tapering of the coronaries with different vessel di-
ameters proximal to and distal from each bifurcation
(9). When using a single-vessel algorithm, the
interpolated reference is determined by the di-
ameters of the proximal and distal branches, which
are by deﬁnition unequal, resulting in a systematic
underestimation of the RVD and %DS in the prox-
imal main branch, and an overestimation of the RVD
and %DS in the distal main branch and side branch
(8). In addition, if the reference diameter is selected
from a normal segment distal to the balloon/stent in
FIGURE 4 Inter–Core Lab Variability Between CRF and Cardialysis Before and After Alignment of Methodology With Regard to the In-Segment
Percentage Side Branch Stenosis
(A) shows a weak agreement between CRF and Cardialysis with regard to the initial measurements of the in-segment side branch stenosis at 9-
month follow-up. (B) shows a considerable improved agreement between CRF and Cardialysis after reanalysis of the total cohort (solid lines ¼
orthogonal regression lines, dashed lines ¼ 95% conﬁdence intervals of these regression lines). (C and D) show Bland-Altman plots of in-
segment side branch stenosis, with the mean between core labs on the horizontal axis plotted against the signed differences on the vertical
axis. The solid lines represent the mean difference, whereas the dashed lines indicate the 95% limits of agreement (1.96  SD of the mean
difference). Note that after reanalysis (D), the mean difference between core labs was smaller, with less wide limits of agreement indicating
improved accuracy and precision. CRF ¼ Cardiovascular Research Foundation.
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312the side branch to calculate the %DS, this can
introduce a subjective random error when compared
with the interpolated reference diameter based on
the vessel contour of the complete region of interest
encompassing the side branch (Figure 2). Further-
more, in the so-called polygon of conﬂuence, the
single-vessel software is not able to deﬁne the
vessel contour automatically and often requires
manual editing, potentially introducing another
factor of random error (Figure 2D, Online Figure 1).Finally, single-vessel algorithms do not recognize
the origin of the distal branches, requiring manual
segmentation, which may introduce another bias
(Figures 2E and 2F).
MANUAL CONTOUR EDITING. Another potential
explanation for the differences in the initial anal-
ysis was the difference in allowance for manual cor-
rections. Lack of smoothness of the automatic
contour delineation, observed when the angiogram is
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313of suboptimal quality (23), should be accepted as
such. Manual editing will introduce subjectivity
(Online Figure 1) and should be allowed only in those
cases where the algorithm erroneously detects other
structures than the vessel contour (side branches, for
example). Analysts should use the “restriction func-
tion” to exclude an area for the automatic contour
detection instead of completely redrawing it them-
selves (Online Figure 2). All corrections and adjust-
ments made after completion of the QCA analysis
should be captured by audit trails and ﬁnal approval
of the QCA should be electronically signed to fulﬁll
the Code of Federal Regulation Title 21, part 11 (CFR
21, part 11) guideline of the U.S. Food and Drug
Administration, which deﬁnes the criteria for reliable
electronic data capturing.
REMAINING INTER–CORE LAB VARIABILITY COMPARED
WITH THE ACCURACY AND PRECISION OF THE
BIFURCATION SOFTWARE. Although the reproduc-
ibility improved remarkably after aligning the core
lab methodology, some systematic bias remained.
This remaining inter–core lab bias for the in-segment
side branch QCA parameters was 0.0227 mm (RVD),
–0.0297 mm (MLD), and 1.84% (%DS) (Table 2). We
believe this is acceptable, considering that the
intrinsic accuracy of the CAAS bifurcation software,
calibrated on a precision phantom model, was com-
parable to this bias: 0.032 mm (side branch RVD),
0.017 mm (side branch MLD), and 0.88% (side
branch %DS) (12).
Inter–core lab variability (standard deviation of
the bias) after reanalysis was 0.2255 mm for the
in-segment side branch RVD, 0.2238 mm for the
in-segment side branch MLD, and 9.45% for the in-
segment %DS. This variability is a little higher as
would have been expected from the phantom vali-
dation, which showed precision of the bifurcation
software of 0.075 mm (side branch RVD), 0.123 mm
(side branch MLD), and 5.35% (side branch %DS) (12).
This somewhat higher variability might be explained
by differences in calibration. Whereas the calibration
in the phantom validation study was performed using
a grid in a static model, the calibration in the current
study was performed using the guiding catheter in
close proximity of the beating heart. Although cali-
bration is preferably performed in the same frame as
the QCA analysis, sometimes this is not possible and
calibration in another frame is needed, which may
introduce extra variability. Given the fact that most
angiograms have a calibration factor ofw0.2000 mm/
pixel, a precision with regard to measuring the
MLD and RVD being around this number can be
considered as acceptable.IMPLICATIONS. Although core lab analysts are
ideally blinded to the treatment groups to minimize
bias, this is not always possible. This is a major limi-
tation, which is not restricted to the current Tryton
IDE trial, but also applies to other trials such as
trials comparing metallic stents with bioresorbable
scaffolds or different types of transcatheter aortic
valves. This is important to realize because device
and pharmaceutical companies cover the costs of the
analysis, which makes core labs not completely in-
dependent. Therefore, it is vital to use a methodology
in which the analysis is performed as automatically
as possible to minimize human subjectivity, with
manual corrections restricted to a minimum.
It seems to remain challenging to aim for stan-
dardization of QCA methodology in various core
labs worldwide (11). Our study has highlighted the
importance of using the same QCA methodology
among different core labs, using software validated
on the same high-resolution calibrated bifurcation
phantom model (10,14,16,24), to ensure reproduc-
ibility and objectivity. Although standard operating
procedures are often not shared because they are
considered intellectual property of the core lab, we
believe it is important to share at least the key
factors of the QCA methodology to ensure re-
producible and generalizable results. Considering
cross-validation, using 2 distinct core labs, of a pre-
speciﬁed proportion of patients enrolled might even
be a valid option to ensure identiﬁcation of any
potential issues precluding data accuracy and
reproducibility.
STUDY LIMITATIONS. Because the agreed QCA rean-
alysis plan included the use of exactly the same
angiographic view and frame, selected by 1 of the
core labs, this study did not investigate the role of
frame selection on the inter–core lab variability.
Although it has been shown that differences in frame
selection from the same angiographic view does not
inﬂuence the accuracy and variability to a large
extent (25), differences in selection of the angio-
graphic view itself is a major determinant of vari-
ability in QCA (26).
CONCLUSIONS
We found a marked inter–core lab variability in QCA
of bifurcation lesions when different QCA methodol-
ogies were used, including difference in software use
(single-vessel vs. dedicated bifurcation software),
differences in allowance for manual vessel contour
correction, and differences in the method for seg-
mentation (automatic vs. manual). However, when
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314the same methodology was used, inter–core lab vari-
ability decreased considerably. More importantly,
QCA results of the trial were affected following
alignment of the methodology. This latter ﬁnding
emphasizes the importance of using the same QCA
methodology among different core labs worldwide.REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Patrick W. Serruys, International Centre for Circulatory
Health, NHLI, Imperial College London, Royal Brompton
Campus, London SW7 2AZ, United Kingdom. E-mail:
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